Basic Epanutin Information

• INN (International Nonproprietary Name): Phenytoin
• Brand Names Available In United Kingdom: Dilantin, Phenytek, Epanutin; generics labelled phenytoin sodium are also supplied by major manufacturers
• ATC Code: N03AB02
• Forms & Dosages: Capsules (30 mg, 100 mg); Chewable Tablets (50 mg, 100 mg); Oral Suspension (125 mg/5 mL); Injectable Solution (50 mg/mL)
• Manufacturers In United Kingdom: Pfizer, Mylan (Viatris), Sun Pharma, Teva, Sandoz, Accord Healthcare
• Registration Status In United Kingdom: Not specified
• OTC / Rx Classification: Prescription Only (Rx) — prescription required

Critical Warnings & Restrictions (Safety First)

Phenytoin is a high‑risk anticonvulsant with a narrow therapeutic index that requires careful prescribing and monitoring.

Seizure control must be balanced against known risks such as teratogenicity and organ impairment.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

• Pregnancy — teratogenic risk; use only after specialist risk–benefit assessment and preconception counselling.
• Severe hepatic impairment — reduced metabolism and higher toxicity risk.
• Significant cardiac disease — IV use may carry cardiovascular risk; monitor closely.
• Porphyria — potential exacerbation; caution advised.
• The elderly — reduced clearance; lower starting doses and closer monitoring recommended.

Contraindications And Monitoring

Absolute and relative contraindications must be checked before starting or continuing epanutin.

Baseline and ongoing monitoring are essential to reduce harm and detect toxicity early.

• Checklist — Baseline Tests And Monitoring
• Full Blood Count (FBC) before starting and periodically thereafter.
• Liver Function Tests (LFTs) baseline and regular monitoring.
• Therapeutic Drug Monitoring — measure phenytoin plasma concentrations after steady state or dose change with typical target range around 10–20 μg/mL.

Missed Dose, Overdose And Action Plans

Clear written action plans reduce emergency presentations and confusion for patients and carers.

For a missed dose, take it when remembered unless it is nearly time for the next dose — never double up.

Recognise overdose signs: ataxia, nystagmus, slurred speech, severe drowsiness leading to coma.

Emergency contact instructions should state to call 999 or present to A&E for suspected severe overdose or prolonged seizures.

Interaction With Activities (Driving, Workplace Safety Under UK Law)

Phenytoin’s common side effects can impair driving and operating machinery.

Drowsiness, dizziness and ataxia may make driving unsafe and must be discussed at dispensing.

Under UK law and DVLA guidance, patients must be seizure‑free for specified periods or notify the DVLA, and must not drive while experiencing medication‑related impairment.

Pharmacist counselling should be documented in the patient record and a written copy offered to the patient.

Q&A — “Can I Drive After Taking It In The UK?”

Short answer: Only if you meet DVLA seizure‑free criteria and are not experiencing medication‑related impairment.

If you have drowsiness, blurred vision, confusion or any seizure, stop driving, tell your GP and inform the DVLA as required.

Seek pharmacist or clinician advice before resuming driving.

Usage Basics

INN, Brand Names Available In The UK

The International Nonproprietary Name is phenytoin.

Brand names encountered include Epanutin and internationally known trade names such as Dilantin and Phenytek, while many supplies are generic phenytoin sodium.

Major manufacturers supplying phenytoin products include Pfizer, Mylan (Viatris), Sun Pharma, Teva, Sandoz and Accord Healthcare.

Legal Classification (POM, P, GSL)

Phenytoin is Prescription Only (POM) across the United Kingdom and must be supplied against a valid prescription.

Prescriptions are issued by GPs, hospital specialists or electronically via the NHS e‑prescription service / NHS App.

• Checklist For Safe Legal Sourcing And Verification
• Obtain phenytoin only from a GPhC‑registered UK pharmacy with a valid prescription.
• Pharmacists must verify identity and the prescription before supply.
• Report suspected adverse reactions via the Yellow Card scheme when appropriate.

Dosing Guide

Standard Regimens (NHS Guidelines)

Typical adult oral starting regimens historically include 100 mg three times daily, titrated to response and plasma concentrations.

For children the initial regimen commonly used is 5 mg/kg/day divided with maintenance of 4–8 mg/kg/day.

Injectable phenytoin (50 mg/mL) is reserved for emergency settings such as status epilepticus and must be given under specialist supervision.

• Monitoring Steps
• Check plasma phenytoin concentrations after steady state or following dose changes.
• Repeat LFTs and FBC at baseline and periodically.
• Assess clinical response and adverse effects at each review.

Adjustments For Comorbidities

Liver disease and hypoalbuminaemia alter phenytoin metabolism and protein binding, increasing free drug levels.

Titrate slowly, check both total and adjusted phenytoin concentrations in low albumin states, and coordinate dose changes with neurology.

Polypharmacy requires careful review because phenytoin is a potent enzyme inducer and can both increase and reduce partner drug levels.

Q&A — “What If I Miss A Dose?”

If you remember soon after the missed dose, take it as soon as possible.

If it is close to the next scheduled dose, skip the missed dose — do not double up.

For repeated missed doses contact your GP or pharmacist because abrupt or irregular dosing increases seizure risk.

Use a daily medicines checklist, dosing aid or blister pack to support adherence and inform the clinic if adherence is poor.

Interaction Chart

Food And Drinks (Alcohol, Tea/Coffee, Diet Habits)

Absorption of phenytoin is variable with food, so advise taking doses at a consistent time relative to meals.

Alcohol increases sedation and can unpredictably affect seizure control, so avoid excess alcohol while taking phenytoin.

High‑protein or low‑albumin states will change free drug levels due to altered protein binding.

Caffeine may worsen tremor or anxiety in some patients taking phenytoin.

Common Drug Conflicts (MHRA Yellow Card Data)

Phenytoin is a potent hepatic enzyme inducer and can reduce the effectiveness of many medicines.

Co‑prescribing with delavirdine is contraindicated.

• High‑Risk Co‑Medications To Avoid Or Monitor
• Oral contraceptives — discuss backup contraception.
• Anticoagulants such as warfarin — check INR frequently.
• Certain antivirals and many psychotropics — consult specialist advice.

User Reports & Trends

Patients commonly describe clear seizure reduction on phenytoin but also report persistent adverse effects that affect quality of life.

• Top 8 Patient‑Reported Issues
• Gum hypertrophy (gingival overgrowth)
• Chronic tiredness and sedation
• Tremor
• Hair changes (thinning or increased growth)
• Skin rashes
• Cosmetic concerns and dental issues
• Concerns about teratogenic risk in pregnancy
• Interaction worries affecting contraception

Validate forum claims with NHS information or a neurology clinic and encourage side‑effect reporting via the Yellow Card scheme.

Access & Purchase Options

Boots, LloydsPharmacy, Superdrug

Community pharmacy chains and independent pharmacies across the UK dispense phenytoin against valid prescriptions.

Pharmacists provide counselling, manage repeat prescriptions and can help with medicine use reviews.

Online Pharmacies And NHS E‑Prescriptions

The NHS e‑prescription service and NHS App enable electronic prescribing with collection or home delivery from registered pharmacies.

When buying online ensure the supplier is GPhC‑registered and that identity checks are performed.

• Checklist For Safe Online Purchase And E‑Prescription Steps
• Use a GPhC‑registered UK pharmacy and confirm prescription origin.
• Check pharmacist contact details and patient information leaflet availability.
• Avoid international e‑shops that lack UK regulation.

• Documentation To Have When Requesting A Repeat
• Valid prescription or NHS e‑prescription token.
• Clinic letter or epilepsy nurse contact if available.
• Current medication list including contraception and anticoagulants.

In our online pharmacy, epanutin is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Mechanism & Pharmacology

Simplified Explanation

Phenytoin is a hydantoin derivative that stabilises neuronal membranes by prolonging the inactivated state of voltage‑gated sodium channels.

This reduces repetitive neuronal firing and the spread of seizure activity.

It is ATC class N03AB02 and is used for focal and generalised tonic‑clonic seizures and IV for acute seizure control.

Clinical Terms

• Definition List
• Narrow Therapeutic Index: Small differences in dose or blood level can cause toxicity or loss of efficacy.
• Protein Binding: Highly protein‑bound; low albumin increases the proportion of active free drug.
• Nonlinear Kinetics: Michaelis–Menten kinetics meaning small dose increases can disproportionately raise plasma levels.

A simple flow: Dose → Hepatic metabolism (variable) → Plasma level (total and free) → Clinical effect or toxicity.

Indications & Off‑Label Uses

MHRA‑Approved Uses

Licensed indications include tonic‑clonic seizures, partial seizures and peri‑operative seizure control as appropriate.

Intravenous phenytoin is an established option for acute seizure control/status epilepticus under specialist supervision.

Off‑Label Practices In NHS And Private Care

Off‑label uses may include short‑term prophylaxis in neurosurgery or certain arrhythmias where alternatives are unsuitable, used only with specialist input.

Newer antiepileptics such as levetiracetam and lamotrigine are increasingly preferred for long‑term maintenance on the NHS for many patients because of better tolerability and fewer interactions.

• When Specialists May Choose Phenytoin
• When rapid IV control is needed and fosphenytoin is not available.
• In patients who have established long‑term seizure control on phenytoin and tolerate it well.
• When cost or formulary considerations influence choice of therapy for short‑term use.

Key Clinical Findings

Recent UK and EU reviews reaffirm phenytoin’s role in certain seizure types and acute settings but highlight its narrow therapeutic window and interaction profile.

• Key Takeaways
• Phenytoin remains effective for tonic‑clonic and partial seizures and as a second‑line IV agent in status epilepticus.
• Nonlinear kinetics and enzyme induction complicate dosing and co‑prescribing.
• Teratogenic risk makes it a less favourable choice for women of childbearing potential if suitable alternatives exist.
• Guidelines increasingly favour levetiracetam and lamotrigine for maintenance due to tolerability and fewer interactions.

For E‑E‑A‑T, include references to MHRA, NICE and specialist neurology guidance when publishing or advising clinically.

Alternatives Matrix

NHS Prescribing Alternatives (Comparison Table)

Pros And Cons Checklist

• Checklist For Selecting An Alternative
• Consider seizure type and EEG/clinical features.
• Discuss reproductive plans and teratogenic risks with women of childbearing potential.
• Review hepatic function, mood comorbidity and concomitant medications.
• Assess driving and work implications where sedation is a concern and monitoring capacity.
• Consult neurology or an epilepsy nurse before switching therapy.

Common Questions (Patient Consultations)

• Why Do My Gums Swell? — Gingival hyperplasia is a recognised effect of phenytoin.
• Maintain excellent dental hygiene, see a dentist regularly and discuss folic acid supplementation with the prescriber.
• Can I Take My Oral Contraception? — Phenytoin induces hepatic enzymes and can reduce contraceptive effectiveness.
• Discuss additional or alternative contraception with your GP or clinic.
• Is It Safe In Pregnancy? — Phenytoin carries teratogenic risk and requires specialist preconception counselling, folic acid supplementation and individual risk–benefit assessment.
• How Often Are Blood Tests Needed? — Baseline LFTs and FBC, and therapeutic drug monitoring after steady state or dose changes; frequency is personalised by the clinician.

Link patients to NHS patient leaflets and specialist clinic contacts when available.

NHS Cost & Access Comparison Table

• Checklist For Verifying Pharmacy Registration And Prescription Validity
• Check GPhC registration number on the website.
• Confirm pharmacist contact details and trading address.
• Keep prescription paperwork or NHS e‑prescription token available when collecting or receiving delivery.
• Consider a Prescription Prepayment Certificate in England if on multiple prescriptions.

Registration & Regulation

MHRA Approval Process

Phenytoin products are licensed with ongoing pharmacovigilance and the MHRA issues safety alerts and monitoring guidance.

The Yellow Card scheme is the route for reporting suspected adverse reactions in the UK.

NHS Prescribing Framework

Prescribing aligns with NHS formularies and local trust policies, with specialists or GPs issuing repeat prescriptions alongside monitoring plans.

Hospital intravenous use requires trained staff, adherence to local dilution and infusion protocols, and cardiovascular monitoring where indicated.

• Checklist For Prescribers
• Confirm indication, contraindications and patient consent.
• Set a monitoring schedule for levels, LFTs and FBC.
• Report serious adverse events via Yellow Card and follow local governance procedures.

Storage & Handling

UK Household Storage (Cold/Damp Climate)

Store phenytoin at room temperature (20–25°C / 68–77°F) and protect from excessive moisture and light.

In UK homes prone to humidity, keep the medicine in original packaging in a dry cupboard away from bathrooms and windowsills.

Keep out of reach of children.

Guidance From NHS And Pharmacists

Shake oral suspensions well before use and follow the printed expiry after opening.

Injectable solutions are handled by hospital pharmacy teams, diluted and stored according to local protocol and used promptly.

• Home Storage Checklist
• Store in original container, cool dry place.
• Do not store in bathroom or near the sink.
• When travelling, carry medication in original packaging with a copy of the prescription and clinician letter if crossing borders.

Guidelines For Proper Use (Practical Patient Guidance)

UK Pharmacist Counselling Style

Pharmacists should provide clear written counselling confirming indication, dose and how to take the medicine consistently with meals.

Explain interactions including contraception and alcohol, and list side effects that should prompt contact with healthcare professionals.

Document advice and supply the patient information leaflet with every dispensed prescription.

NHS Patient Safety Advice

Provide a medicines card with emergency contact details and a seizure action plan for patients at risk of prolonged seizures.

Emphasise never to stop phenytoin abruptly, to notify prescribers when starting or stopping other medicines and to report adverse effects via Yellow Card.

Encourage regular dental review for gum health and liaison with specialist neurology for dose titration.

• Patient Takeaways Checklist
• Take doses at the same time each day relative to meals.
• Carry an epilepsy/seizure card and emergency contact information.
• Attend scheduled blood tests and dental checks.

• Emergency Signs Requiring Immediate Care
• Severe rash or signs of anaphylaxis.
• Prolonged seizures or cluster seizures not responding to rescue medication.
• Severe drowsiness, confusion or signs of overdose.

Delivery Across United Kingdom

Key Clinical Findings

Phenytoin retains a role in seizure control but is used with greater caution than in past decades because of toxicity, interactions and teratogenic risk.

For status epilepticus, benzodiazepines remain first line with phenytoin or fosphenytoin as established second‑line options where indicated.

• Recent Trends
• Greater use of newer antiepileptic drugs for maintenance therapy on the NHS where appropriate.
• Continued reliance on phenytoin for some acute settings and for patients with a long‑standing, tolerated response.
• Ongoing need for targeted blood monitoring and multidisciplinary care.

Registration & Regulation

Products containing phenytoin are subject to MHRA licence conditions and post‑marketing surveillance in the UK.

Prescribers should follow NHS formularies and local policies when initiating and repeating therapy.

Storage & Handling

Store oral phenytoin at room temperature and protect from moisture and light.

Follow printed expiry after opening oral suspensions and follow local protocols for IV handling in hospital.

Guidelines For Proper Use

Pharmacists and prescribers should provide written medicines information, document counselling and ensure monitoring plans are in place.

Provide clear instructions about not stopping treatment abruptly and about when to seek emergency help.